Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk
Open Access
- 3 March 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 127 (12) , 2822-2830
Abstract
Chronic inflammation is an established risk factor for colorectal cancer (CRC), and polymorphisms in genes regulating inflammatory processes appear to alter the risk for neoplasia and the efficacy of nonsteroidal anti‐inflammatory drugs in CRC chemoprevention. We examined the association between selected inflammation gene polymorphisms and CRC risk. In a large population‐based case‐control study with 1,795 CRC cases and 1,805 controls from the German DACHS study, we evaluated 5 putative functional inflammatory pathway polymorphisms in PRODH, PTGS1 and UBD genes. PTGS1 G213G was significantly associated with an increased CRC risk [odds ratio (OR), 1.19; 95% confidence interval (CI), 1.03–1.39; p = 0.02] comparing minor allele carriers with major allele homozygotes. This risk estimate was consistent across locations and stages of CRC (range of ORs, 1.15–1.20). Carriage of the minor allele of UBD I68T was significantly associated with advanced stages of CRC and with CRC below 65 years of age (OR, 1.23; 95% CI, 1.04–1.45; p = 0.02 and OR, 1.32; 95% CI, 1.05–1.67; p = 0.02, respectively). Our results support a role of variants in inflammatory pathway genes in CRC susceptibility and progression.Keywords
This publication has 60 references indexed in Scilit:
- Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenomaInternational Journal of Colorectal Disease, 2009
- Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association studyBMC Cancer, 2008
- Pro-inflammatory prostaglandins and progression of colorectal cancerCancer Letters, 2008
- A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasiaThe Pharmacogenomics Journal, 2008
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in MenGastroenterology, 2008
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritizationNucleic Acids Research, 2006
- Combinatorial microRNA target predictionsNature Genetics, 2005
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- Inflammation and cancerNature, 2002